Chemotherapy of the Transplantable Adenocarcinoma (R-3327) of the Copenhagen Rat

Authors:
  • NBN.L. Block
    N.L. Block
  • FCF. Camuzzi
    F. Camuzzi
  • JDJ. Denefrio
    J. Denefrio
  • MTM. Troner
    M. Troner
  • ACA. Claflin
    A. Claflin
  • BSB. Stover
    B. Stover
  • VPV.A. Politano
    V.A. Politano

Abstract
A number of therapeutic agents including L-asparaginase, Actinomycin-D, CCNU, Hydroxyurea, 5-FU, Cis-platinum, Cyclophosphamide, orchiectomy, Adriamycin and DES alone and in various combinations has been applied against the Dunning R-3327 rat prostatic adenocarcinoma subline G. We have found a parallel between the results of this study and those of similar therapeutic application to the human tumor. We conclude that this animal model may prove to be a useful screening system for agents against human prostatic cancer.